Abnormal immunological indicators associated with disease severity and mortality in
patients with COVID-19 have been reported in several observational studies. However …

Background: The recent outbreak of coronavirus disease 2019 (COVID-19) has been rapidly
spreading on a global scale and poses a great threat to human health. Acute respiratory …

Introduction An excessive systemic pro-inflammatory state increases the risk of severe
disease and mortality in patients with coronavirus disease 2019 (COVID-19). However, there …

Background COVID-19 has spread widely worldwide, causing millions of deaths. We aim to
explore the association of immunological features with COVID-19 severity. Methods We …

Aims This study aimed to make a comparison between the clinical laboratory-related factors,
complete blood count (CBC) indices, cytokines, and lymphocyte subsets in order to …

The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) spread rapidly all over
the world in late 2019 and caused critical illness and death in some infected patients. This …

Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

Background Markedly elevated levels of proinflammatory cytokines and defective type-I
interferon responses were reported in patients with coronavirus disease 2019 (COVID-19) …

Summary Coronavirus disease 2019 (COVID‐19) is a clinical syndrome caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …

Clinical symptoms of COVID-19 include fever, cough, and fatigue which may progress to
acute respiratory distress syndrome (ARDS). The main hematological laboratory findings …